Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

This is a major source of cardiovascular morbidity and mortality. We have never been able to treat lipoprotein(a) until now.” ...

Revolutionary drug Lepodisiran dramatically lowers Lp(a) cholesterol, a major heart attack risk factor. Learn about this ...

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be ...

High levels of a chemical that is believed to be behind sudden and inexplicable heart attacks and strokes could soon have ...

While plant sterols and stanols can aid in reducing cholesterol levels, similar to statins, they should not be viewed as a ...

About a quarter of people risk heart attacks and strokes because they inherited a kind of cholesterol that statin drugs can’t ...

Plant sterols and stanols share a structural resemblance to cholesterol, allowing them to compete for absorption in the ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

A single dose of an siRNA molecule reduces elevated lipoprotein(a) — a major, but to date, largely untreatable risk factor ...

A new drug in clinical trials is showing promise in lowering a key genetic risk factor for heart attacks and ...

Lilly's drug is one of several being tested to treat high Lp(a), a risk factor for heart disease that affects an estimated ...